Cardiac arrest & resuscitation

Lower versus higher blood pressure targets in comatose patients resuscitated from out‐of‐hospital cardiac arrest—Protocol for a secondary Bayesian analysis of the box trial

Acta Anaesthesiol ScandPublished Protocol for a secondary Bayesian analysis of the BOX randomised trial

Study context

Population
Comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA) during intensive careBOX trial
Participants
789 patients
Planned comparison
Lower vs higher BP targets
Methodological detailsBayesian logistic and linear regressions, weakly informative priors, skeptical and evidence-based priors in sensitivity analyses, heterogeneity of treatment effects assessment, Secondary outcomes: neurological outcome after 365 days, and plasma neuron-specific enolase after 48 h, Heterogeneity of treatment effects on mortality by lactate at admission, time to ROSC, primary shockable rhythm, age, hypertension, ST-elevation MI
  • Bayesian logistic and linear regressions
  • Weakly informative priors
  • Skeptical and evidence-based priors in sensitivity analyses
  • Heterogeneity of treatment effects assessment
  • Secondary outcomes: neurological outcome after 365 days, and plasma neuron-specific enolase after 48 h
  • Heterogeneity of treatment effects on mortality by lactate at admission, time to ROSC, primary shockable rhythm, age, hypertension, ST-elevation MI

No results yet. This paper sets out the design of a trial; its results are to come.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Lower versus higher blood pressure targets in comatose patients resuscitated from out‐of‐hospital cardiac arrest—Protocol for a secondary Bayesian analysis of the box trial. Acta Anaesthesiol Scand. Published 21 February 2024. doi:10.1111/aas.14392

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.